All Stories

  1. Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women

    Article • International Journal of Women s Health, July 2015, Dove Medical Press

    Dr Andreas Lammerich, Beate Dr. Gertz

  2. A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects

    Article • Drug Design Development and Therapy, May 2015, Dove Medical Press

    Dr Andreas Lammerich